A new guideline from the American Society of Clinical Oncology (ASCO) offers clear, evidence-based direction for treating blood cancers during pregnancy and shows that many patients can safely receive timely cancer care without compromising fetal health. The guideline underscores that survival outcomes for pregnant patients with leukemia or lymphoma can match those of non-pregnant patients when treatment follows established protocols.
This article was originally published on MedicalXpress.com

